BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen QT, Choi YK. Targeting Antigens for Universal Influenza Vaccine Development. Viruses 2021;13:973. [PMID: 34073996 DOI: 10.3390/v13060973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mittal N, Sengupta N, Malladi SK, Reddy P, Bhat M, Rajmani RS, Sedeyn K, Saelens X, Dutta S, Varadarajan R. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions. Viruses 2021;13:1710. [PMID: 34578291 DOI: 10.3390/v13091710] [Reference Citation Analysis]
2 Semple SC, Leone R, Barbosa CJ, Tam YK, Lin PJC. Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics. Pharmaceutics 2022;14:398. [DOI: 10.3390/pharmaceutics14020398] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Carascal MB, Pavon RDN, Rivera WL. Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response. Front Immunol 2022;13:878943. [PMID: 35663997 DOI: 10.3389/fimmu.2022.878943] [Reference Citation Analysis]